Archean Chemical Industries Ltd (ACI) — shareholding pattern, promoter holding, financials and share price
About Archean Chemical Industries Ltd (ACI)
Archean Chemical Industries Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as ACI and on the BSE under scrip code 543657. Its ISIN is INE128X01021.
Archean Chemical Industries Limited is India's largest exporter of bromine and industrial salt in Fiscal 2021. The company is the leading specialty marine chemical manufacturer in India and is focused on producing and exporting bromine, industrial salt, and sulphate of potash to customers around the world. [1]
Archean Chemical Industries Limited is an India‑based specialty marine chemicals manufacturer producing industrial salt, liquid bromine, sulphate of potash (SOP) and bromine derivatives from integrated facilities at Hajipir with captive brine fields, port access and an R&D base; its products serve agrochemicals, pharmaceuticals, flame retardants, water treatment and global industrial customers.
The company remains heavily export‑oriented with exports contributing nearly 79% of operating revenues; consolidated 9MFY26 revenues were INR8,016.7 million (≈10.6% YoY growth) while consolidated PAT fell to INR931.8 million due to operational disruptions in bromine, higher costs and lower derivatives utilisation, highlighting resilient sales but margin pressure in FY26.
Listed peers in Specialty Chemicals: Clean Science & Technology Ltd, Balaji Amines Ltd, Elantas Beck India Ltd, Galaxy Surfactants Ltd, Neogen Chemicals Ltd, Fineotex Chemical Ltd.
Valuation & Returns
10 Jul 2026At ₹525.75 a share on 10 Jul 2026, Archean Chemical Industries Ltd (ACI) was valued at a price-to-earnings ratio of 61.58x against an industry P/E of 45.11x and a price-to-book of 3.36x on a book value of ₹156.68 per share as of Mar 2026. Solomo computes return on equity of 5.45% and return on capital employed of 7.2% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 61.58x
- Industry P/E
- 45.11x
- P/B
- 3.36x
- EPS (TTM)
- ₹8.54
- Book value / share
- ₹156.68
- ROE
- 5.45%
- ROCE
- 7.2%
- ROA
- 3.96%
- Debt / equity
- 0.24x
- Dividend yield
- 0.48%
- EBITDA margin
- 24.58%
- 52-week range
- ₹483.1 – ₹727.8
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Archean Chemical Industries Ltd (ACI) reported revenue of ₹1,081 crore, net profit of ₹105 crore and earnings per share of ₹8.66. That compares with revenue of ₹1,041 crore and net profit of ₹162 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹301 crore and net profit ₹12 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 1,130 | 1,441 | 1,330 | 1,041 | 1,081 |
| Net profit (₹ cr) | 188 | 383 | 319 | 162 | 105 |
| EPS (₹) | 19.54 | 31.09 | 25.85 | 13.14 | 8.66 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 7.05% | -10.26% | 3.85% |
| Profit growth | 18.31% | -26.17% | -34.99% |
| Stock price CAGR | - | 1% | -21% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 53.43% of Archean Chemical Industries Ltd (ACI) (unchanged from the previous quarter), foreign institutional investors (FII) hold 11% and domestic institutional investors (DII) hold 24.18%. Promoters have pledged 24.5% of their holding. Market capitalisation was ₹6,491 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2022.
Largest disclosed public shareholders in Jun 2026: Sbi Small Cap Fund 6.88%, Dsp Small Cap Fund 3.06%, Hdfc Mutual Fund - Hdfc Multi Cap Fund 3%, Goldman Sachs Funds - Goldman Sachs India Equity Portfolio 2.46%, Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund 1.11%, Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110 1.06%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 53.43% | 24.5% | 11% | 24.18% | 46.57% |
| Mar 2026 | 53.43% | 17.3% | 11.09% | 25.82% | 46.57% |
| Dec 2025 | 53.43% | 9.2% | 11.08% | 25.25% | 46.57% |
| Sep 2025 | 53.44% | 7.3% | 11.15% | 25.52% | 46.56% |
| Jun 2025 | 53.44% | 7% | 11.05% | 24.68% | 46.56% |
| Mar 2025 | 53.44% | 7% | 10.94% | 23.18% | 46.56% |
| Dec 2024 | 53.44% | 5.3% | 10.65% | 22.85% | 46.56% |
| Sep 2024 | 53.45% | 4.6% | 10.17% | 22.01% | 46.55% |